WHO ICTRP trial

using oxytocin alone in one group compared to using dinoprostone insert for…

CTRI/2021/03/031755 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2021/03/031755
Public title using oxytocin alone in one group compared to using dinoprostone insert for priming followed by oxytocin for inducing labour in term prelabour rupture of membranes .
Scientific title oyxtocin alone versus dinoprostone insert followed by oxytocin for inducing labour in term prelabour rupture of membranes
Primary sponsor VMMC and Safdarjung hospital
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Countries India
Conditions Health Condition 1: O759- Complication of labor and delivery, unspecified
Interventions Intervention1: Oxytocin: Patients of one group will recieve oxytocin infusion at 4miu/min and it will be doubled every 30mins to a maximum of 64miu/min for primigravida and 32miu/min for multigravida or until 5 contractions each, lasting…
Registration date Aug 3, 2021
Target size 150
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations